Clinical Trial Update: Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating pembrolizumab in combination with the DPX-Survivac vaccine and cyclophosphamide for advanced ovarian, primary perito…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DPX-Survivac Vaccine
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Advanced Cancer, Ovarian Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING